138 related articles for article (PubMed ID: 38093749)
1. Valvular Endothelium: A Genetically Susceptible Predilection Site for Calcific Aortic Valve Stenosis.
Bäck M
JACC Basic Transl Sci; 2023 Nov; 8(11):1473-1474. PubMed ID: 38093749
[TBL] [Abstract][Full Text] [Related]
2. Palmdelphin Deficiency Evokes NF-κB Signaling in Valvular Endothelial Cells and Aggravates Aortic Valvular Remodeling.
Han Y; Zhang J; Yang Z; Jian W; Zhu Y; Gao S; Liu Y; Li Y; He S; Zhang C; Li Y; You B; Liu J; Du J
JACC Basic Transl Sci; 2023 Nov; 8(11):1457-1472. PubMed ID: 38093741
[No Abstract] [Full Text] [Related]
3. Palmdelphin Regulates Nuclear Resilience to Mechanical Stress in the Endothelium.
Sáinz-Jaspeado M; Smith RO; Plunde O; Pawelzik SC; Jin Y; Nordling S; Ding Y; Aspenström P; Hedlund M; Bastianello G; Ascione F; Li Q; Demir CS; Fernando D; Daniel G; Franco-Cereceda A; Kroon J; Foiani M; Petrova TV; Kilimann MW; Bäck M; Claesson-Welsh L
Circulation; 2021 Nov; 144(20):1629-1645. PubMed ID: 34636652
[TBL] [Abstract][Full Text] [Related]
4. PALMD regulates aortic valve calcification via altered glycolysis and NF-κB-mediated inflammation.
Wang S; Yu H; Gao J; Chen J; He P; Zhong H; Tan X; Staines KA; Macrae VE; Fu X; Jiang L; Zhu D
J Biol Chem; 2022 May; 298(5):101887. PubMed ID: 35367413
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
[TBL] [Abstract][Full Text] [Related]
6. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
8. Phenome-wide analyses establish a specific association between aortic valve PALMD expression and calcific aortic valve stenosis.
Li Z; Gaudreault N; Arsenault BJ; Mathieu P; Bossé Y; Thériault S
Commun Biol; 2020 Aug; 3(1):477. PubMed ID: 32859967
[TBL] [Abstract][Full Text] [Related]
9. Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets.
Goody PR; Hosen MR; Christmann D; Niepmann ST; Zietzer A; Adam M; Bönner F; Zimmer S; Nickenig G; Jansen F
Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):885-900. PubMed ID: 32160774
[TBL] [Abstract][Full Text] [Related]
10. Cellular Mechanisms of Valvular Thickening in Early and Intermediate Calcific Aortic Valve Disease.
Ohukainen P; Ruskoaho H; Rysa J
Curr Cardiol Rev; 2018; 14(4):264-271. PubMed ID: 30124158
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.
Tanase DM; Valasciuc E; Gosav EM; Floria M; Costea CF; Dima N; Tudorancea I; Maranduca MA; Serban IL
Cells; 2022 Aug; 11(17):. PubMed ID: 36078071
[TBL] [Abstract][Full Text] [Related]
12. PALMD as a novel target for calcific aortic valve stenosis.
Bossé Y; Mathieu P; Thériault S
Curr Opin Cardiol; 2019 Mar; 34(2):105-111. PubMed ID: 30608251
[TBL] [Abstract][Full Text] [Related]
13.
Junco-Vicente A; Solache-Berrocal G; Del Río-García Á; Rolle-Sóñora V; Areces S; Morís C; Martín M; Rodríguez I
Front Cardiovasc Med; 2022; 9():989539. PubMed ID: 36337884
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for valvular calcification.
Chen HY; Engert JC; Thanassoulis G
Curr Opin Endocrinol Diabetes Obes; 2019 Apr; 26(2):96-102. PubMed ID: 30694830
[TBL] [Abstract][Full Text] [Related]
16. Valvular heart disease: the influence of changing etiology on nosology.
Boudoulas H; Vavuranakis M; Wooley CF
J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
[TBL] [Abstract][Full Text] [Related]
17. ApoC-III is a novel inducer of calcification in human aortic valves.
Schlotter F; de Freitas RCC; Rogers MA; Blaser MC; Wu PJ; Higashi H; Halu A; Iqbal F; Andraski AB; Rodia CN; Kuraoka S; Wen JR; Creager M; Pham T; Hutcheson JD; Body SC; Kohan AB; Sacks FM; Aikawa M; Singh SA; Aikawa E
J Biol Chem; 2021; 296():100193. PubMed ID: 33334888
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition to calcific aortic stenosis and mitral annular calcification.
Kutikhin AG; Yuzhalin AE; Brusina EB; Ponasenko AV; Golovkin AS; Barbarash OL
Mol Biol Rep; 2014 Sep; 41(9):5645-63. PubMed ID: 24903972
[TBL] [Abstract][Full Text] [Related]
19. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature.
Narang N; Lang RM; Liarski VM; Jeevanandam V; Hofmann Bowman MA
Front Cardiovasc Med; 2017; 4():14. PubMed ID: 28396860
[TBL] [Abstract][Full Text] [Related]
20. Severe valvular heart disease in patients on chronic dialysis. A five-year multicenter French survey.
Baglin A; Hanslik T; Vaillant JN; Boulard JC; Moulonguet-Doleris L; Prinseau J
Ann Med Interne (Paris); 1997; 148(8):521-6. PubMed ID: 9538397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
